Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Class H 00874
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- HKD 20.60
- Day Range
- HKD 20.55–21.00
- 52-Week Range
- HKD 18.48–24.20
- Bid/Ask
- HKD 20.65 / HKD 20.80
- Market Cap
- HKD 33.57 Bil
- Volume/Avg
- 171,202 / 789,748
Key Statistics
- Price/Earnings (Normalized)
- 9.06
- Price/Sales
- 0.40
- Dividend Yield (Trailing)
- 3.98%
- Dividend Yield (Forward)
- 3.98%
- Total Yield
- 3.98%
Company Profile
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is active in the healthcare sector. The company manufactures pharmaceutical products including antibiotics, vasodilators, and traditional Chinese medical therapies in preparations such as injection, tablet, capsule, powder, cream, and oral liquid. Its segment includes Great Southern TCM; Great Health; Great Commerce and others. The company generates maximum revenue from the Great Commerce segment.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Large Value
- Total Number of Employees
- 28,048
- Website
- https://www.gybys.com.cn
Comparables
Valuation
|
Metric
|
00874
|
002393
|
300108
|
|---|---|---|---|
Price/Earnings (Normalized) | 9.06 | 24.89 | — |
Price/Book Value | 0.83 | 0.82 | — |
Price/Sales | 0.40 | 3.43 | 1.94 |
Price/Cash Flow | 8.06 | 18.21 | — |
Price/Earnings
00874
002393
300108
Financial Strength
|
Metric
|
00874
|
002393
|
300108
|
|---|---|---|---|
Quick Ratio | 1.27 | 3.22 | 0.10 |
Current Ratio | 1.64 | 3.73 | 0.22 |
Interest Coverage | 11.66 | 250.56 | −2.06 |
Quick Ratio
00874
002393
300108
Profitability
|
Metric
|
00874
|
002393
|
300108
|
|---|---|---|---|
Return on Assets (Normalized) | 4.81% | 2.91% | −13.89% |
Return on Equity (Normalized) | 10.46% | 3.50% | — |
Return on Invested Capital (Normalized) | 7.27% | 2.66% | −19.68% |
Return on Assets
00874
002393
300108
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Vhcwmnzwm | Kzm | $79.1 Bil | |||
| Merck KGaA ADR
MKKGY
| Mdfpwkvsy | Nllhvj | $72.0 Bil | |||
| Haleon PLC ADR
HLN
| Pxymjwr | Qshx | $37.3 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Thsrynq | Ygdpb | $12.8 Bil | |||
| Viatris Inc
VTRS
| Zbdnyffdn | Fcvh | $12.7 Bil | |||
| Catalent Inc
CTLT
| Rgwhhdqqd | Xfqprp | $10.2 Bil | |||
| Perrigo Co PLC
PRGO
| Lvyqwwtnz | Rxnb | $3.5 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Qxbmkdjz | Zdhvtx | $3.4 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Bbctxcprv | Twh | $2.9 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Djzghdzxr | Xmrj | $2.8 Bil |